ORAMED PHARMACEUTICALS INC. Retained Earnings
ORAMED PHARMACEUTICALS INC. (ORMP) had Retained Earnings of -$6.96 million as of 2026-06-30, per its 10-Q filed 2026-08-10.
Financial Statements › Balance Sheet › Equity › Equity, Including Portion Attributable to Noncontrolling Interest › Equity, Attributable to Parent
us-gaap:RetainedEarningsAccumulatedDeficit · last filed 2026-08-10
- 2026-06-30: Retained Earnings (Accumulated Deficit) -$6.96M.
- 2026-03-31: Retained Earnings (Accumulated Deficit) -$85.12M.
- 2025-12-31: Retained Earnings (Accumulated Deficit) -$123.44M.
- 2025-09-30: Retained Earnings (Accumulated Deficit) -$122.58M.
| Period end | Retained Earnings (Accumulated Deficit) | Retained Earnings (Accumulated Deficit) as first filed |
|---|---|---|
| 2026-06-30 | -$6.96M 10-Q · filed 2026-08-10 | |
| 2026-03-31 | -$85.12M 10-Q · filed 2026-05-19 | |
| 2025-12-31 | -$123.44M 10-Q · filed 2026-08-10 | |
| 2025-09-30 | -$122.58M 10-Q · filed 2025-11-13 | |
| 2025-06-30 | -$170.97M 10-Q · filed 2025-08-14 | |
| 2025-03-31 | -$184.26M 10-Q · filed 2025-05-15 | |
| 2024-12-31 | -$176.62M 10-K · filed 2026-03-26 | |
| 2024-09-30 | -$166.43M 10-Q · filed 2024-11-07 | |
| 2024-06-30 | -$146.81M 10-Q · filed 2024-08-14 | |
| 2024-03-31 | -$156.02M 10-Q · filed 2024-05-09 | |
| 2023-12-31 | -$157.56M 10-K · filed 2025-03-27 | |
| 2023-09-30 | -$170.89M 10-Q · filed 2023-11-09 | |
| 2023-06-30 | -$167.67M 10-Q · filed 2023-08-10 | |
| 2023-03-31 | -$166.48M 10-Q · filed 2023-05-11 | |
| 2022-12-31 | -$163.08M 10-K · filed 2024-03-06 | |
| 2022-09-30 | -$154.54M 10-Q · filed 2022-11-10 | |
| 2022-06-30 | -$147.48M 10-Q · filed 2022-08-10 | |
| 2022-03-31 | -$136.94M 10-Q · filed 2022-05-12 | |
| 2021-12-31 | -$126.52M 10-K · filed 2023-03-06 | |
| 2021-11-30 | -$122.74M 10-Q · filed 2022-01-11 | |
| 2021-08-31 | -$114.85M 10-QT · filed 2022-03-30 | |
| 2021-05-31 | -$108.00M 10-Q · filed 2021-07-14 | |
| 2021-02-28 | -$102.79M 10-Q · filed 2021-04-13 | |
| 2020-11-30 | -$98.18M 10-Q · filed 2021-01-14 | |
| 2020-08-31 | -$92.61M 10-K · filed 2021-11-24 | |
| 2020-05-31 | -$89.62M 10-Q · filed 2020-07-07 | |
| 2020-02-29 | -$87.33M 10-Q · filed 2020-04-06 | |
| 2019-11-30 | -$83.65M 10-Q · filed 2020-01-09 | |
| 2019-08-31 | -$81.10M 10-K · filed 2020-11-24 | |
| 2019-05-31 | -$78.82M 10-Q · filed 2019-07-10 | |
| 2019-02-28 | -$74.75M 10-Q · filed 2019-04-10 | |
| 2018-11-30 | -$71.05M 10-Q · filed 2019-01-14 | |
| 2018-08-31 | -$69.22M 10-K · filed 2019-11-27 | |
| 2018-05-31 | $700.00K 10-K · filed 2018-11-28 | -$66.30M 10-Q · filed 2018-07-12 |
| 2018-02-28 | -$61.94M 10-Q · filed 2018-04-09 | |
| 2017-11-30 | -$59.03M 10-Q · filed 2018-01-11 | |
| 2017-08-31 | -$56.50M 10-K · filed 2018-11-28 | |
| 2017-05-31 | -$53.80M 10-Q · filed 2017-07-06 | |
| 2017-02-28 | -$51.84M 10-Q · filed 2017-04-05 | |
| 2016-11-30 | -$48.65M 10-Q · filed 2017-01-11 | |
| 2016-08-31 | -$46.02M 10-K · filed 2017-11-29 | |
| 2016-05-31 | -$41.26M 10-Q · filed 2016-07-06 | |
| 2016-02-29 | -$39.26M 10-Q · filed 2016-04-06 | |
| 2015-11-30 | -$37.44M 10-Q · filed 2016-01-13 | |
| 2015-08-31 | -$35.05M 10-K · filed 2016-11-25 | |
| 2015-05-31 | -$32.94M 10-Q · filed 2015-07-01 | |
| 2015-02-28 | -$31.35M 10-Q · filed 2015-04-03 | |
| 2014-11-30 | -$29.72M 10-Q · filed 2015-01-08 | |
| 2014-08-31 | -$27.82M 10-K · filed 2015-11-25 | |
| 2014-05-31 | -$26.19M 10-Q · filed 2014-07-14 | |
| 2014-02-28 | -$24.36M 10-Q · filed 2014-04-10 | |
| 2013-11-30 | -$23.25M 10-Q · filed 2014-01-14 | |
| 2013-08-31 | -$22.12M 10-K · filed 2014-11-14 | -$22.12M 10-K · filed 2013-11-27 |
| 2013-05-31 | -$21.33M 10-Q · filed 2013-07-17 | |
| 2013-02-28 | -$20.08M 10-Q · filed 2013-04-11 | |
| 2012-11-30 | -$18.85M 10-Q · filed 2012-12-26 | |
| 2012-08-31 | -$17.89M 10-K · filed 2013-11-27 | -$17.87M 10-K · filed 2012-12-12 |
| 2012-05-31 | -$16.56M 10-Q · filed 2012-07-12 | |
| 2012-02-29 | -$16.01M 10-Q · filed 2012-04-04 | |
| 2011-11-30 | -$15.03M 10-Q · filed 2012-01-12 | |
| 2011-08-31 | -$14.55M 10-K · filed 2012-12-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Zentalis Pharmaceuticals, Inc. (ZNTL) | United States | $0.196B | -2.48 |
| Nkarta, Inc. (NKTX) | United States | $0.205B | -1.73 |
| Fortress Biotech, Inc. (FBIO) | United States | $0.188B | 0.91 |
| ALX ONCOLOGY HOLDINGS INC (ALXO) | United States | $0.187B | -3.52 |
| PepGen Inc. (PEPG) | United States | $0.186B | -1.73 |
| AN2 Therapeutics, Inc. (ANTX) | United States | $0.185B | -4.84 |
| Foghorn Therapeutics Inc. (FHTX) | United States | $0.213B | -4.43 |
| Organogenesis Holdings Inc. (ORGO) | United States | $0.182B | -3.70 |
| Eledon Pharmaceuticals, Inc. (ELDN) | United States | $0.219B | -3.23 |
| Whitehawk Therapeutics, Inc. (WHWK) | United States | $0.221B |